Texas To Receive 1.9 Million Doses of COVID-19 Vaccine for Week of April 19
News Release
April 16, 2021
April 20: The first paragraph of this release was updated to reflect approximately 100,000 additional doses allocated to 300 additional providers.
More than 1.9 million doses of COVID-19 vaccine will be shipped to providers across Texas next week. The Texas Department of State Health Services is allocating 846,620 first doses to 679 providers in 124 counties. Those numbers reflect additional first doses allocated between April 16 and 20, and the weekly allocation table has been updated. DSHS is ordering 686,640 second doses for people vaccinated a few weeks ago. An estimated 500,000 additional first and second doses are expected to be available to pharmacy locations, federally-qualified health centers and dialysis centers as allocated directly by the federal government.
Despite the pause in the use of the Johnson & Johnson COVID-19 vaccine, nearly two million Texans got a shot in the last week. Texas has now administered more than 15.5 million doses of vaccine. Nearly 10 million people have received at least one dose, and 6.25 million are now fully vaccinated. About 44 percent of all eligible Texans have gotten a COVID-19 shot, and 28 percent are fully vaccinated.
Vaccine continues to be available across the state at large vaccine hubs, community vaccination providers, and special clinics operated by the DSHS public health regions, local health departments and Texas Military Forces. People can register with the Texas Public Health Vaccine Scheduler at getthevaccine.dshs.texas.gov, which will match them with a vaccine appointment through a participating public health entity in their county.
A CDC advisory committee will meet next Friday to further consider the Johnson & Johnson vaccine after a few reports of rare but serious blood clot events prompted a pause in its use. The pause allows time for more information to be gathered and to advise health care providers on how to recognize and treat these blood clots should they occur. The advisory committee is expected to make a recommendation at that meeting on whether and how to resume the use of the Johnson & Johnson vaccine.
People can find more information on COVID-19 vaccine at COVID-19 (Coronavirus Disease 2019) | Texas DSHS.
Helpful links
-30-
(News Media Contact: pressofficer@dshs.texas.gov)
News Release
April 16, 2021
April 20: The first paragraph of this release was updated to reflect approximately 100,000 additional doses allocated to 300 additional providers.
More than 1.9 million doses of COVID-19 vaccine will be shipped to providers across Texas next week. The Texas Department of State Health Services is allocating 846,620 first doses to 679 providers in 124 counties. Those numbers reflect additional first doses allocated between April 16 and 20, and the weekly allocation table has been updated. DSHS is ordering 686,640 second doses for people vaccinated a few weeks ago. An estimated 500,000 additional first and second doses are expected to be available to pharmacy locations, federally-qualified health centers and dialysis centers as allocated directly by the federal government.
Despite the pause in the use of the Johnson & Johnson COVID-19 vaccine, nearly two million Texans got a shot in the last week. Texas has now administered more than 15.5 million doses of vaccine. Nearly 10 million people have received at least one dose, and 6.25 million are now fully vaccinated. About 44 percent of all eligible Texans have gotten a COVID-19 shot, and 28 percent are fully vaccinated.
Vaccine continues to be available across the state at large vaccine hubs, community vaccination providers, and special clinics operated by the DSHS public health regions, local health departments and Texas Military Forces. People can register with the Texas Public Health Vaccine Scheduler at getthevaccine.dshs.texas.gov, which will match them with a vaccine appointment through a participating public health entity in their county.
A CDC advisory committee will meet next Friday to further consider the Johnson & Johnson vaccine after a few reports of rare but serious blood clot events prompted a pause in its use. The pause allows time for more information to be gathered and to advise health care providers on how to recognize and treat these blood clots should they occur. The advisory committee is expected to make a recommendation at that meeting on whether and how to resume the use of the Johnson & Johnson vaccine.
People can find more information on COVID-19 vaccine at COVID-19 (Coronavirus Disease 2019) | Texas DSHS.